Patrick Dolezal

Stock Analyst at LifeSci Capital

(2.53)

# 2,192

Out of 5,172 analysts

2

Total ratings

100%

Success rate

22.61%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Patrick Dolezal

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	NGNE Neurogene	Initiates: Outperform	$50	$19.05	+162.47%	1	Jan 26, 2026
	KOD Kodiak Sciences	Initiates: Outperform	$40	$22.25	+79.78%	1	Oct 23, 2025

Neurogene

Jan 26, 2026

Initiates: Outperform

Price Target: $50

Current: $19.05

Upside: +162.47%

Kodiak Sciences

Oct 23, 2025

Initiates: Outperform

Price Target: $40

Current: $22.25

Upside: +79.78%